as 10-29-2025 9:37am EST
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
| Founded: | 2008 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 89.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 130.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.62 - $1.84 | Next Earning Date: | 11-13-2025 |
| Revenue: | $678,078 | Revenue Growth: | 2519.47% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
ZTEK Breaking Stock News: Dive into ZTEK Ticker-Specific Updates for Smart Investing
Newsfile
7 days ago
MT Newswires
9 days ago
Newsfile
9 days ago
Simply Wall St.
21 days ago
ACCESS Newswire
23 days ago
Simply Wall St.
4 months ago
ACCESS Newswire
4 months ago
ACCESS Newswire
5 months ago
The information presented on this page, "ZTEK Zentek Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.